News

Vamorolone (VBP15) Top Line Data Shows Improvements in Strength and Endurance in Boys with Duchenne Muscular Dystrophy

Rockville, MD – 26 June 2018
Vamorolone (VBP15) Top Line Data Shows Improvements in Strength and Endurance in Boys with Duchenne Muscular Dystrophy.

ReveraGen BioPharma, Inc.
155 Gibbs Street
Suite 433
Rockville, MD 20850
Phone: 240-672-0295
Email: eric.hoffman@reveragen.com

At ReveraGen BioPharma, we are committed to improving the lives of neuromuscular disease patients.

Conflict of Interest Policy
Terms and Conditions
Privacy Policy

News

Vamorolone (VBP15) Top Line Data Shows Improvements in Strength and Endurance in Boys with Duchenne Muscular Dystrophy

News Archives